{
  "../data/ABEONA-THERAPEUTICS-INC/1996/10-Q/0000318306-96-000002/EX-10.18.txt": {
    "contract_id": "1995 Stock Option Plan (Unknown)",
    "title": "1995 Stock Option Plan (Unknown)",
    "contract_type": "License Agreement",
    "summary": "This is a stock option plan for Access Pharmaceuticals, Inc., as amended on 1996-03-28. It outlines the terms and conditions for granting stock options and stock appreciation rights to employees, consultants, and directors.",
    "execution_date": "1995-09-14",
    "effective_date": "1995-09-14",
    "upfront_payment": null,
    "exclusivity_grant_type": null,
    "oem_type": null,
    "licensor_name": "Access Pharmaceuticals, Inc.",
    "licensee_name": "low sale prices of Common Stock on the stock exchange or market on which Common Stock is primarily traded on the date as of which such value is being determined or",
    "patents_count": 0,
    "products_count": 0,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/1996/10-Q/0000318306-96-000002/EX-10.18.txt",
      "year": "1996",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:16:13.235921",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/1996/10-Q/0000318306-96-000003/EX-10.19.txt": {
    "contract_id": "LEASE AGREEMENT (Unknown)",
    "title": "LEASE AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between Pollock Realty Corporation (licensor) and Access Pharmaceuticals, Inc. (licensee). Grant type: Nonexclusive. Upfront payment: $7,459.70. Territory: 1 region(s)",
    "execution_date": "None",
    "effective_date": "None",
    "upfront_payment": 7459.7,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "Pollock Realty Corporation",
    "licensee_name": "Access Pharmaceuticals, Inc.",
    "patents_count": 0,
    "products_count": 0,
    "territories_count": 1,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/1996/10-Q/0000318306-96-000003/EX-10.19.txt",
      "year": "1996",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:16:18.090113",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/1996/10-K/0000950146-96-000501/EX-10.16.txt": {
    "contract_id": "PATENT PURCHASE AGREEMENT (Unknown)",
    "title": "PATENT PURCHASE AGREEMENT (Unknown)",
    "contract_type": "Patent Purchase Agreement",
    "summary": "License agreement between David F. Ranney (licensor) and ACCESS PHARMACEUTICALS, INC (licensee). Grant type: Nonexclusive. Licenses 7 patent(s). Upfront payment: $7,500.00. Executed: 1994-04-05",
    "execution_date": "1994-04-05",
    "effective_date": "None",
    "upfront_payment": 7500.0,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "David F. Ranney",
    "licensee_name": "ACCESS PHARMACEUTICALS, INC",
    "patents_count": 7,
    "products_count": 0,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/1996/10-K/0000950146-96-000501/EX-10.16.txt",
      "year": "1996",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:16:23.146352",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/1996/10-K/0000950146-96-000501/EX-10.17.txt": {
    "contract_id": "FIRST AMENDMENT to PATENT PURCHASE AGREEMENT (Unknown)",
    "title": "FIRST AMENDMENT to PATENT PURCHASE AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between David F. Ranney (licensor) and ACCESS Pharmaceuticals, Inc. (licensee). Grant type: Nonexclusive. Upfront payment: $7,500.00. Executed: 1996-01-23",
    "execution_date": "1996-01-23",
    "effective_date": "None",
    "upfront_payment": 7500.0,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "David F. Ranney",
    "licensee_name": "ACCESS Pharmaceuticals, Inc.",
    "patents_count": 0,
    "products_count": 0,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/1996/10-K/0000950146-96-000501/EX-10.17.txt",
      "year": "1996",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:16:25.346942",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/1997/10-Q/0000318306-97-000010/EX-10.12.txt": {
    "contract_id": "LICENSE AGREEMENT BETWEEN THE DOW CHEMICAL COMPANY AND THE COMPANY DATED JUNE 30, 1997 (Unknown)",
    "title": "LICENSE AGREEMENT BETWEEN THE DOW CHEMICAL COMPANY AND THE COMPANY DATED JUNE 30, 1997 (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between THE DOW CHEMICAL COMPANY (licensor) and Access Pharmaceuticals, Inc. (licensee). Grant type: Exclusive. Territory: 1 region(s). Executed: 1997-06-30",
    "execution_date": "1997-06-30",
    "effective_date": "1997-06-30",
    "upfront_payment": null,
    "exclusivity_grant_type": "Exclusive",
    "oem_type": null,
    "licensor_name": "THE DOW CHEMICAL COMPANY",
    "licensee_name": "Access Pharmaceuticals, Inc.",
    "patents_count": 0,
    "products_count": 0,
    "territories_count": 1,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/1997/10-Q/0000318306-97-000010/EX-10.12.txt",
      "year": "1997",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:16:31.654515",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/1997/10-K/0000318306-97-000003/EX-10.19.txt": {
    "contract_id": "PLATINATE HPMA COPOLYMER ROYALTY AGREEMENT (Unknown)",
    "title": "PLATINATE HPMA COPOLYMER ROYALTY AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "This is a Platinate HPMA Copolymer Royalty Agreement between The London School of Pharmacy, University of London and Access Pharmaceuticals, Inc. dated November 19, 1996. It grants Access Pharmaceuticals exclusive rights to develop, manufacture, and sell products related to Cisplatin HPMA Copolymer technology worldwide, based on patents and know-how jointly owned by both parties. The agreement outlines terms for royalties, obligations, confidentiality, and termination.",
    "execution_date": "1996-11-19",
    "effective_date": "1996-11-19",
    "upfront_payment": null,
    "exclusivity_grant_type": "Exclusive",
    "oem_type": null,
    "licensor_name": "The School of Pharmacy, University of London",
    "licensee_name": "Access Pharmaceuticals, Inc",
    "patents_count": 0,
    "products_count": 1,
    "territories_count": 1,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/1997/10-K/0000318306-97-000003/EX-10.19.txt",
      "year": "1997",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:16:43.040977",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/1998/10-Q_A/0000318306-98-000012/EX-10.13.txt": {
    "contract_id": "AGREEMENT BETWEEN ACCESS PHARMACEUTICALS, INC. AND BLOCK DRUG COMPANY, INC. (Unknown)",
    "title": "AGREEMENT BETWEEN ACCESS PHARMACEUTICALS, INC. AND BLOCK DRUG COMPANY, INC. (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between Block Drug Company, Inc. (licensor) and Access Pharmaceuticals, Inc. (licensee). Grant type: Nonexclusive. Licenses 1 patent(s). Licenses 1 product(s). Territory: 1 region(s). Executed: 1998-03-05",
    "execution_date": "1998-03-05",
    "effective_date": "1998-03-05",
    "upfront_payment": null,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "Block Drug Company, Inc.",
    "licensee_name": "Access Pharmaceuticals, Inc.",
    "patents_count": 1,
    "products_count": 1,
    "territories_count": 1,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/1998/10-Q_A/0000318306-98-000012/EX-10.13.txt",
      "year": "1998",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:16:51.732760",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/1998/10-Q/0000318306-98-000007/EX-10.12.txt": {
    "contract_id": "LICENSE AGREEMENT BETWEEN STRAKAN LIMITED AND ACCESS PHARMACEUTICALS, INC. (Unknown)",
    "title": "LICENSE AGREEMENT BETWEEN STRAKAN LIMITED AND ACCESS PHARMACEUTICALS, INC. (Unknown)",
    "contract_type": "License Agreement",
    "summary": "This is a license agreement between Access Pharmaceuticals, Inc. and Strakan Ltd. for the development and commercial exploitation of a zinc compound patent for human use in dermatological and topical products. Strakan receives an exclusive global license.",
    "execution_date": "1998-02-26",
    "effective_date": "1998-02-26",
    "upfront_payment": null,
    "exclusivity_grant_type": "Exclusive",
    "oem_type": null,
    "licensor_name": "Access Pharmaceuticals, Inc.",
    "licensee_name": "Strakan Ltd.",
    "patents_count": 0,
    "products_count": 1,
    "territories_count": 1,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/1998/10-Q/0000318306-98-000007/EX-10.12.txt",
      "year": "1998",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:16:57.481671",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/1998/10-Q/0000318306-98-000008/EX-10.13.txt": {
    "contract_id": "AGREEMENT BETWEEN ACCESS PHARMACEUTICALS, INC. AND BLOCK DRUG COMPANY, INC. (Unknown)",
    "title": "AGREEMENT BETWEEN ACCESS PHARMACEUTICALS, INC. AND BLOCK DRUG COMPANY, INC. (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between Block Drug Company, Inc. (licensor) and Access Pharmaceuticals, Inc. (licensee). Licenses 1 patent(s). Licenses 1 product(s). Territory: 1 region(s). Executed: 1998-03-05",
    "execution_date": "1998-03-05",
    "effective_date": "None",
    "upfront_payment": null,
    "exclusivity_grant_type": null,
    "oem_type": null,
    "licensor_name": "Block Drug Company, Inc.",
    "licensee_name": "Access Pharmaceuticals, Inc.",
    "patents_count": 1,
    "products_count": 1,
    "territories_count": 1,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/1998/10-Q/0000318306-98-000008/EX-10.13.txt",
      "year": "1998",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:17:03.011904",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/1998/10-Q/0000318306-98-000008/EX-10.15.txt": {
    "contract_id": "REGISTRATION RIGHTS AGREEMENT (Unknown)",
    "title": "REGISTRATION RIGHTS AGREEMENT (Unknown)",
    "contract_type": "Registration Rights Agreement",
    "summary": "This is a Registration Rights Agreement between Access Pharmaceuticals, Inc. and the Investors listed on Schedule I, regarding the registration of the resale of shares under the Securities Act of 1933.",
    "execution_date": "None",
    "effective_date": "None",
    "upfront_payment": null,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "Access Pharmaceuticals, Inc.",
    "licensee_name": "Investors",
    "patents_count": 0,
    "products_count": 1,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/1998/10-Q/0000318306-98-000008/EX-10.15.txt",
      "year": "1998",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:17:06.884966",
    "mtime": 1750965720.0
  }
}